thymine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zonneville, J | 1 |
| Wang, M | 1 |
| Alruwaili, MM | 1 |
| Smith, B | 1 |
| Melnick, M | 1 |
| Eng, KH | 1 |
| Melendy, T | 1 |
| Park, BH | 1 |
| Iyer, R | 1 |
| Fountzilas, C | 1 |
| Bakin, AV | 1 |
1 other study available for thymine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Line, Tumor; Cy | 2021 |